India Diabetes Care Devices Market Analysis and Forecasts to 2015

Product Code GDA00194
Publication Date April 2009
Publisher GlobalData
Product Type Report
Pages 79
ISBN Number not applicable
Change currency
PDF £2,215.00 €2,667 $3,502 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

India Diabetes Care Devices Market Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to the India diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in India.

Scope

  • The report provides Diabetes care devices market information broken down into detailed categories and segments in India.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in India.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Executive Summary
  • 4 Definitions of Markets Covered in the Report
    • 4.1 Diabetic Care Devices
    • 4.2 Glucose Monitoring Devices
      • 4.2.1 Blood Glucose Meters
      • 4.2.2 Blood Glucose Strips
    • 4.3 Insulin Delivery
      • 4.3.1 InsulinPens
      • 4.3.2 Insulin Syringes
      • 4.3.3 Insulin Pumps
      • 4.3.4 Traditional Insulin Pump Accessories
  • 5 Healthcare Sector Review
    • 5.1 Healthcare Expenditure
    • 5.2 Healthcare Infrastructure
      • 5.2.1 Healthcare Personnel Data
      • 5.2.2 Healthcare Facilities Data
    • 5.3 Healthcare Policy
  • 6 Regulation System
    • 6.1 Medical Equipment Approval
    • 6.2 Central Drugs Authority of India (CDAI)
    • 6.3 Medical Device Regulatory Authority of India (MDRAI)
    • 6.4 Classification of medical devices
      • 6.4.1 Registration Period
  • 7 Pricing and Reimbursement
    • 7.1 Pricing and Reimbursement
  • 8 Distribution Structure
    • 8.1 Distribution Structure
  • 9 Diabetes Care Devices In India
    • 9.1 Diabetes Care Devices, India, Overall Revenue ($ mn), Historic, 2000-2015
    • 9.2 Diabetes Care Devices, India, Category Volume (Units), 2000-2015
    • 9.3 Diabetes Care Devices, India, Cross Category Analysis, 2000-2015
    • 9.4 Diabetes Care Devices, Market Dynamics
      • 9.4.1 Market Drivers
      • 9.4.2 Market Restraints
    • 9.5 Indian Diabetes Epidemiology
    • 9.6 Diabetes Care Devices, India Company Share (2006-2007)
    • 9.7 Future Outlook
  • 10 Glucose Monitoring In India
    • 10.1 Glucose Monitoring Overall Revenue (2000-2015)
    • 10.2 Glucose Monitoring Overall Volume (2000-2015)
    • 10.3 Glucose Monitoring, India, Cross Segment Analysis, 2000-2015
    • 10.4 Glucose Monitoring Average Price (2000-2015)
      • 10.4.1 Glucose Monitoring Market Dynamics
    • 10.5 Glucose Monitoring Distribution Share (2007-2008)
    • 10.6 Glucose Monitoring, India, Company Share (2006-2007)
  • 11 Insulin Delivery In India
    • 11.1 Insulin Delivery Overall Revenue (2000-2015)
      • 11.1.1 Insulin Pens Revenue (2000-2015)
    • 11.2 Insulin Delivery Overall Volume (2000-2015)
    • 11.3 Insulin Delivery, India, Cross Segment Analysis, 2000-2015
    • 11.4 Insulin Delivery Average Price (2000-2015)
      • 11.4.1 Insulin Delivery Market Dynamics
    • 11.5 Insulin Delivery Distribution Share (2007-2008)
    • 11.6 Insulin Delivery, India, Company Share (2006-2007)
  • 12 Overview of Key Companies in India Diabetes Care Devices Market
    • 12.1 Novo Nordisk A/S Company Profile
      • 12.1.1 Company Overview
      • 12.1.2 Novo Nordisk A/S Pipeline Products
    • 12.2 Hindustan Syringes & Medical Devices Ltd. Company Profile
      • 12.2.1 Company Overview
    • 12.3 F. Hoffmann-La Roche Ltd. Company Profile
      • 12.3.1 Company Overview
      • 12.3.2 Value Chain Analysis
      • 12.3.3 F. Hoffmann-La Roche Ltd Pipeline Products
    • 12.4 LifeScan, Inc. Company Profile
      • 12.4.1 Company Overview
      • 12.4.2 LifeScan, Inc. Pipeline Products
    • 12.5 Eli Lilly and Company, Company Profile
      • 12.5.1 Company Overview
      • 12.5.2 Value Chain Analysis
      • 12.5.3 Eli Lilly and Company Pipeline Products
    • 12.6 Becton, Dickinson and Company, Company Profile
      • 12.6.1 Company Overview
      • 12.6.2 Value Chain Analysis
    • 12.7 Mehar Healthcare Corporation Company Profile
      • 12.7.1 Company Overview
  • 13 Financial Deals Landscape
    • 13.1 Merger
      • 13.1.1 Canere Actives & Fine Chemicals Merges with Nicholas Piramal India
    • 13.2 Partnerships
      • 13.2.1 Nicholas Piramal India and ARKRAY Forms ARKRAY PIRAMAL Medical
  • 14 Recent Developments
    • 14.1 Product News
      • 14.1.1 Mar 02, 2009: Generex to Present Oral-Lyn at International Conference on Advances in Diabetes and Insulin Therapy
  • 15 APPENDIX
    • 15.1 GlobalData Research Methodology
    • 15.2 Coverage
    • 15.3 Secondary Research
    • 15.4 Primary Research
    • 15.5 Models
    • 15.6 Forecasts
    • 15.7 Expert Panel Validation
    • 15.8 Currency Conversion
    • 15.9 Contact Us
    • 15.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Number of Doctors by Specialty in India, 2000-2006
    • Table 2: Wards by Specialty in India, 2000-2006
    • Table 3: Diabetes Care Devices, India, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 4: Diabetes Care Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 5: Diabetes Care Devices, India, Category Volume (Units), Historic, 2000-2008
    • Table 6: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2008-2015
    • Table 7: Diabetes Care Devices, India, Cross Category Analysis, 2000-2015
    • Table 8: Diabetes Burden in India
    • Table 9: Diabetes Care Devices, India Company Share by Revenue ($ mn), 2006-2007
    • Table 10: Glucose Monitoring, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 11: Glucose Monitoring, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 12: Glucose Monitoring, India, Volume (Units) by Segment, Historic, 2000-2008
    • Table 13: Glucose Monitoring, India, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 14: Glucose Monitoring, India, Cross Segment Analysis, 2000-2015
    • Table 15: Glucose Monitoring, India, Average Price ($), Historic, 2000-2008
    • Table 16: Glucose Monitoring, India, Average Price ($), Forecast, 2008-2015
    • Table 17: Glucose Monitoring, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 18: Glucose Monitoring, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 19: Insulin Delivery, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 20: Insulin Delivery, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 21: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 22: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 23: Insulin Delivery, India, Volume (Units) by Segment, Historic, 2000-2008
    • Table 24: Insulin Delivery, India, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 25: Insulin Delivery, India, Cross Segment Analysis, 2000-2015
    • Table 26: Insulin Delivery, India, Average Price ($), Historic, 2000-2008
    • Table 27: Insulin Delivery, India, Average Price ($), Forecast, 2008-2015
    • Table 28: Insulin Delivery, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 29: Insulin Delivery, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 30: Novo Nordisk A/S Pipeline Products by Equipment Type
    • Table 31: Novo Nordisk A/S Pipeline Products by Development Stage
    • Table 32: Novo Nordisk A/S Pipeline Products by Therapy Area
    • Table 33: Novo Nordisk A/S Pipeline Products by Clinical Trials
    • Table 34: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
    • Table 35: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
    • Table 36: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area
    • Table 37: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 38: LifeScan, Inc. Pipeline Products by Development Stage
    • Table 39: LifeScan, Inc. Pipeline Products by Therapy Area
    • Table 40: LifeScan, Inc. Pipeline Products by Clinical Trials
    • Table 41: LifeScan, Inc. Pipeline Products by News Summary
    • Table 42: Eli Lilly and Company Pipeline Products by Equipment Type
    • Table 43: Eli Lilly and Company Pipeline Products by Development Stage
    • Table 44: Eli Lilly and Company Pipeline Products by Therapy Area
    • Table 45: Eli Lilly and Company Pipeline Products by Clinical Trials
    • Table 46: Eli Lilly and Company Pipeline Products by News Summary
    • Table 47: Canere Actives & Fine Chemicals Merges With Nicholas Piramal India
    • Table 48: Nicholas Piramal India And ARKRAY Forms ARKRAY PIRAMAL Medical
    • Table 49: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in India, 2000-2005
    • Figure 2: Private Expenditure on Health by Source, 2005
    • Figure 3: Proposed Medical Equipment Classification in India, 2005
    • Figure 4: Diabetes Care Devices, India, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 5: Diabetes Care Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 6: Diabetes Care Devices, India, Category Volume (Units), Historic, 2000-2008
    • Figure 7: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2008-2015
    • Figure 8: Diabetes Care Devices, India, Cross Category Analysis, 2000-2015
    • Figure 9: Diabetes Burden in India
    • Figure 10: Diabetes Care Devices, India Company Share (%), 2007
    • Figure 11: Glucose Monitoring, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 12: Glucose Monitoring, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 13: Glucose Monitoring, India, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 14: Glucose Monitoring, India, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 15: Glucose Monitoring, India, Cross Segment Analysis, 2000-2015
    • Figure 16: Glucose Monitoring, India, Company Share (%), 2007
    • Figure 17: Insulin Delivery, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 18: Insulin Delivery, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 19: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 20: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 21: Insulin Delivery, India, Cross Segment Analysis, 2000-2015
    • Figure 22: Insulin Delivery, India, Company Share (%), 2007
    • Figure 23: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 24: Eli Lilly and Company Value Chain Analysis
    • Figure 25: Becton, Dickinson and Company Value Chain Analysis
    • Figure 26: GlobalData Methodology